Insys Therapeutics beats by $0.28, beats on revenue

|About: Insys Therapeutics, Inc. (INSY)|By:, SA News Editor

Insys Therapeutics (NASDAQ:INSY): Q2 EPS of $0.58 beats by $0.28.

Revenue of $55.7M (+196.0% Y/Y) beats by $2.93M.